Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
Patents for C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325)
12/2010
12/15/2010CN101914063A N, N'-di-[3- hydroxyl-4-(2- benzimidazole) phenyl] urea and application thereof as zinc ion fluorescent probe
12/14/2010US7851625 Process for preparing 2,3-disubstituted indoles
12/14/2010US7851580 The inorganic Si-O-Si network can absorb significant amount of H3PO4; pendant imidazole rings have high degree of local motion; 2-trimethoxysilylpropylthiomethyl-1H-benzimidazole; fuel cell
12/14/2010US7851071 Nitrogen-containing heterocycle derivative and organic electroluminescent element using the same
12/14/2010CA2437944C Acylated indanyl amines and their use as pharmaceuticals
12/14/2010CA2373433C Spiroimidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them
12/14/2010CA2355939C Antihistaminic spiro compounds
12/09/2010US20100311968 Deprotection of boc-protected compounds
12/09/2010US20100308310 Emissive aryl-heteroaryl acetylenes
12/08/2010EP2257528A2 1 ibeta-hydroxysteroid dehydrogenase inhibitors
12/08/2010CN101910137A 1,3-dialkyl-benzimidazole halogenides exhibiting regeneration, anti-inflammatory and antimicrobial activity
12/08/2010CN101906074A Preparation method of dibazol hydrochloride
12/08/2010CN101397275B Method for preparing 2-( p-aminophenyl) benzimidazole-5-amine
12/08/2010CN101333225B Method for preparing biimidazole, bisbenzimidaze salts and metal complexes thereof and applications
12/07/2010US7846925 such as 5-(1,3-benzodioxol-5-ylmethylene)-1,3-thiazolidine-2,4-dione, used for the treatment and/or prophylaxis of autoimmune, cardiovascular or neurodegenerative disorders, inflammatory or kidney diseases, bacterial or viral infections, platelet aggregation, cancer, transplant rejection or lung injuries
12/02/2010US20100305131 Substituted Aminopropionic Derivatives as Neprilysin inhibitors
12/02/2010US20100304363 Peptide compounds for detecting or inhibiting sars coronavirus and application thereof
12/02/2010US20100301312 Organic electroluminescence device
12/01/2010CN101903375A Carboxyl- or hydroxyl-substituted benzimidazole derivatives
12/01/2010CN101899007A Pyridine compound
12/01/2010CN101899006A 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents
12/01/2010CN101899003A Quinoline derivative-N-oxide ligand as well as preparation method and application thereof
11/2010
11/30/2010US7842817 Such as 1,3-Bis(4-chlorobenzyl)-1,3-dihydrobenzoimidazol-2-ylideneamine; cardiovascular, cognitive, gastrointestinal, respiratory, psychological, urogenital, nervous system, sleep and metabolic disorders
11/30/2010US7842816 Mitogen-activated protein kinase kinase inhibitors such as 2-amino-3-methylbutyric acid 2-{[6-(4-bromo-2-chlorophenylamino)-7-fluoro-3-methyl-3H -benzoimidazole-5-carbonyl]-aminooxy}-ethylester, used for the treatment of diseases, such as cancer and inflammation in mammals
11/30/2010US7842693 For therapy of rheumatoid arthritis, multiple sclerosis, transplant rejection, dermnatitis, eczema, urticaria, vasculitis, inflammatory bowel disease, food allergy and encephalomyelitis
11/30/2010CA2460682C Ester compound and medical use thereof
11/30/2010CA2335477C Sulfonamide inhibitors of aspartyl protease
11/25/2010WO2010134014A1 Bridged spiro [2.4] heptane derivatives as alx receptor and/or fprl2 agonists
11/25/2010WO2010133794A1 Anticancer compound and pharmaceutical composition containing the same
11/25/2010WO2010133169A1 Method for preparing d-biotin
11/25/2010WO2010116380A3 A one pot process for preparing 2-butyl-3-[[2'-(1h-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1,3-diazaspiro [4, 4] non-1-en-4-one (irbesartan)
11/25/2010WO2009116089A3 Novel intermediates and method for synthesis of 4'-[(1,4'-dimethyl-2'-propyl-[2,6'- bi-1hbenzimidazol]-l-yl)methyl]-1,1-biphenyl]-2-carboxylic acid.
11/25/2010US20100298321 Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
11/25/2010US20100298291 Fused bicyclic-substituted amines as histamine-3 receptor ligands
11/25/2010US20100297038 Benzimidazole Derivatives And Their Use As Cooling Agents
11/25/2010CA2762233A1 Anticancer compound and pharmaceutical composition containing the same
11/25/2010CA2760885A1 Bridged spiro [2.4] heptane derivatives as alx receptor and/or fprl2 agonists
11/24/2010EP2253328A1 Cycloalkyl inhibitors of potassium channel function
11/24/2010EP2253315A1 Alkoxyphenylpropanoic acid derivatives
11/24/2010CN101896472A HEDGEHOG pathway antagonists and therapeutic applications thereof
11/24/2010CN101896471A Fluoroalkyl substituted benzimidazole cannabinoid agonists
11/24/2010CN101896470A Dual-acting benzoimidazole derivative and their use as antihypertensive agents
11/24/2010CN101891689A Preparation method of hydrochloric acid gamma-hydroxy bendamustine
11/24/2010CN101891688A Preparation method for bendazol in industrialized production
11/23/2010US7838683 Synthesis of irbesartan
11/23/2010CA2377309C Compounds for the modulation of ppar.gamma. activity
11/18/2010WO2010132810A1 Deuterium modified benzimidazoles
11/18/2010WO2010132247A1 Benzimidazole derivatives useful as trp m8 receptor modulators
11/18/2010WO2010056644A8 1-(arylsulfonyl)-4-(piperazin-1-yl)-1h-benzimidazoles as 5-hydroxytryptamine-6 ligands
11/18/2010WO2010036613A8 Novel cyclic benzimidazole derivatives useful anti-diabetic agents
11/18/2010US20100292465 Catalysts containing n-heterocyclic carbenes for enantioselective synthesis
11/18/2010US20100292317 Antimicrobial and radioprotective compounds
11/18/2010US20100292276 Benzimidazole derivatives useful as trp m8 receptor modulators
11/18/2010US20100292263 Cgrp receptor antagonists with tertiary amide, sulfonamide, carbamite and urea groups
11/17/2010EP2251326A1 Heterocyclic compound
11/17/2010EP2251324A1 Heteroaryl-alkylcarbamate compounds and their use as inhibitors of the faah enzyme
11/17/2010EP2250154A1 Benzimidazole derivatives and their use as cooling agents
11/17/2010EP2170260B1 Azo derivatives containing a pyrazolinone unit for dyeing keratin fibres
11/17/2010EP1838306B1 Novel 2-amino benzimidazole derivatives and their use as modulators of small-conductance calcium-activated potassium channels
11/17/2010EP0773940B2 Process for synthesis of substituted sulphoxides
11/16/2010US7834054 Hydroxamates as therapeutic agents
11/16/2010US7833632 Nitrogenous heterocycle derivative, and organic electroluminescent element employing the same
11/16/2010CA2477474C Cyclic n-substituted alpha imino carboxylic acids for selective inhibition of collagenase
11/16/2010CA2436846C Thioether substituted imidazoquinolines
11/11/2010WO2010128516A2 Process for the preparation of flibanserin involving novel intermediates
11/11/2010WO2010127452A1 5-oxo-ete receptor antagonist compounds
11/11/2010WO2010105179A3 Inhibitors of beta-secretase
11/11/2010WO2009143178A3 Pde10 inhibitors and related compositions and methods
11/11/2010US20100286406 1,3- dialkylbenzimidazole halogenides exhibiting regenerative, anti-inflammatory, and antimicrobial activity
11/11/2010US20100286202 New Compounds
11/11/2010US20100286144 Heteroaryl derivatives
11/10/2010CN101880211A Method for preparing sulfonyl ring thiourea from mono-sulfonyl diamine in aqueous phase
11/10/2010CN101575317B Method for preparing 4,5,6,7-tetrahydro-1H-benzimidazo-5-methanoic acid derivatives
11/09/2010US7829586 Aryl-substituted nitrogen-containing heterocyclic compounds
11/09/2010CA2540845C Aminobenzimidazoles as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders
11/04/2010WO2010126811A1 Cxcr3 receptor antagonists
11/04/2010WO2010125402A1 Imidazole derivatives and their use as modulators of cyclin dependent kinases
11/04/2010WO2010068287A3 Small molecule modulators of hepatocyte growth factor (scatter factor) activity
11/04/2010US20100280252 Poly(ethylene glycol) containing chemically disparate endgroups
11/04/2010US20100280042 Quinazoline derivatives for the treatment of tumours
11/04/2010US20100279991 Tetrahydro-cyclopentyl pyrazole cannabinoid modulators
11/04/2010US20100279873 Halogen Alkoxy Spirocyclic Tetramic and Tetronic Acid Derivatives
11/04/2010US20100279871 Optically active (r)-aryloxypropionic acid amides and herbicidal composition comprising same
11/04/2010US20100279122 Benzimidazole, Benzoxazole and Benzothiazole Derivatives, Optical Film Comprising them and Method of Producing thereof
11/04/2010US20100277060 Electroluminescent device
11/04/2010CA2759083A1 Imidazole derivatives and their use as modulators of cyclin dependent kinases
11/03/2010EP2246334A1 Medicinal composition for inhibiting amyloid- protein deposition
11/03/2010EP2245016A1 Substituted amino-benzimidazoles, medicaments comprising said compound, their use and their method of manufacture
11/03/2010EP2001855B1 Benzimidazole derivatives and their use for modulating the gabaa receptor complex
11/03/2010EP1966188B1 Enantioselective preparation of benzimidazole derivatives and their salts
11/03/2010CN101875638A Method for synthesizing 2-aminomethyl benzimidazole by microwave irradiation
11/03/2010CN101875637A Organic material and application thereof in organic electroluminescence devices
11/02/2010US7825258 such as 2-[2-(3-Chloro-benzyl)-5,6-difluoro-benzoimidazol-1-yl]-2,N-dicyclohexyl-acetamide, used for the treatment and/or prophylaxis of diseases that are affected by Farnesoid-X-receptor agonists; hyperlipemia; hypercholesterolemia
11/02/2010US7825145 Antimicrobial and radioprotective compounds
11/02/2010CA2405741C Sodium salt of an azo derivative of 5-aminosalicylic acid
10/2010
10/28/2010WO2010124097A2 Transcription factor modulating compounds and methods of use thereof
10/28/2010WO2010123139A1 Arylcarboxamide derivative having sulfamoyl group
10/28/2010US20100273850 4-heteroaryl-substituted phenoxyphenylacetic acid derivatives
10/28/2010US20100273831 Fluoro alkyl substituted benzimidazole cannabinoid agonists
10/28/2010US20100273813 Novel n-phenylacetamide inhibitors of the enzyme soat-1 and pharmaceutical/cosmetic compositions comprised thereof
1 ... 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 ... 154